2015
DOI: 10.1016/j.ajog.2015.01.012
|View full text |Cite
|
Sign up to set email alerts
|

A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature

Abstract: Uterine sarcomas are rare uterine malignancies that are difficult to diagnose preoperatively. Because of cases of disseminated sarcoma after laparoscopic hysterectomy, the role of power morcellators in gynecologic surgery has been questioned. Morcellation is an integral part of making laparoscopic surgery possible for the removal of large uterine leiomyomata, and the development of power morcellation has increased efficiency during these procedures. Minimally invasive surgery has demonstrated benefits that inc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(23 citation statements)
references
References 72 publications
0
23
0
Order By: Relevance
“…34Y38 However, those reports were highly biased and of low quality; thus, whether power morcellation up-stages occult LMS and affects survival is still an open question. 39,40 Therefore, large prospective studies focusing on the effects of morcellation in LMS are warranted. Furthermore, to make decisions on appropriate types of surgery, it will be necessary to identify the most accurate and reliable preoperative diagnostic tools.…”
Section: Discussionmentioning
confidence: 99%
“…34Y38 However, those reports were highly biased and of low quality; thus, whether power morcellation up-stages occult LMS and affects survival is still an open question. 39,40 Therefore, large prospective studies focusing on the effects of morcellation in LMS are warranted. Furthermore, to make decisions on appropriate types of surgery, it will be necessary to identify the most accurate and reliable preoperative diagnostic tools.…”
Section: Discussionmentioning
confidence: 99%
“…When developing their recommendations, the FDA used available reports of occult sarcoma in a pooled analysis to derive an estimate of 1:352 risk of occult sarcoma in women undergoing hysterectomy or myomectomy for presumed myomas. Their estimate has been criticized based on concerns about the quality of the data of the 9 studies included, as well as the potential for publication bias and inclusion of only retrospectives studies (17)(18)(19). The largest study in the pooled analysis included only 1429 patients.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, the chance of dispersing fragments of tissue in multiple directions in both benign and malignant conditions [7,8]. That risk is independent of the form in which morcellation is carried out.…”
Section: Discussionmentioning
confidence: 99%